The Massachusetts pharmaceutical company linked to a fungal meningitis outbreak that caused 44 deaths has reported nearly $21.2 million in both salaries to key executives and credit card reimbursements since December 2011.
Company linked to meningitis cases paid execs more than $20M last year
The National Law Journal
January 22, 2013
This article requires free registration
This article requires free registration to Law.com. Please sign in or register to read the full text.